Covered recipient · General Payments record
NERIY IZKHAKOV
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2021–2024
$1,901.98
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $762.79 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $138.07 | 7 |
| Medtronic, Inc. | $123.62 | 4 |
| Radius Health, Inc. | $112.63 | 5 |
| Amgen Inc. | $111.33 | 5 |
| Lilly USA, LLC | $53.81 | 2 |
| Xeris Pharmaceuticals, Inc. | $47.85 | 2 |
| ABBVIE INC. | $42.06 | 2 |
| DEXCOM, INC. | $41.02 | 2 |
| Alexion Pharmaceuticals, Inc. | $29.89 | 1 |
| Ascendis Pharma Inc | $26.64 | 1 |
| Ascensia Diabetes Care US Inc. | $18.09 | 1 |
| Insulet Corporation | $17.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.11 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103975282 | CMS |
| ABBVIE INC. | $19.95 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103975284 | CMS |
| Alexion Pharmaceuticals, Inc. | $29.89 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093938304 | CMS |
| Amgen Inc. | $27.60 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115755273 | CMS |
| Amgen Inc. | $25.01 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115755283 | CMS |
| Amgen Inc. | $17.27 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115755291 | CMS |
| Amgen Inc. | $18.78 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115755299 | CMS |
| Amgen Inc. | $22.67 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115755307 | CMS |
| Ascendis Pharma Inc | $26.64 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133849489 | CMS |
| Ascensia Diabetes Care Us Inc. | $18.09 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089087682 | CMS |
| Dexcom, Inc. | $15.80 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153325313 | CMS |
| Dexcom, Inc. | $25.22 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153325315 | CMS |
| Insulet Corporation | $17.78 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116792188 | CMS |
| Lilly USA, LLC | $19.00 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135249347 | CMS |
| Lilly USA, LLC | $34.81 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135176869 | CMS |
| Medtronic, Inc. | $26.85 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119289260 | CMS |
| Medtronic, Inc. | $27.51 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119289258 | CMS |
| Medtronic, Inc. | $35.89 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119289262 | CMS |
| Medtronic, Inc. | $33.37 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119289264 | CMS |
| Novo Nordisk Inc | $24.91 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097181254 | CMS |
| Novo Nordisk Inc | $14.70 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096617874 | CMS |
| Novo Nordisk Inc | $19.35 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097784405 | CMS |
| Novo Nordisk Inc | $19.61 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097740284 | CMS |
| Novo Nordisk Inc | $15.62 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097452715 | CMS |
| Novo Nordisk Inc | $17.59 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097379844 | CMS |
| Novo Nordisk Inc | $26.29 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097542086 | CMS |
| Radius Health, Inc. | $26.53 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089979945 | CMS |
| Radius Health, Inc. | $17.90 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089979950 | CMS |
| Radius Health, Inc. | $19.87 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089979953 | CMS |
| Radius Health, Inc. | $19.43 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089979957 | CMS |
| Radius Health, Inc. | $28.90 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089979962 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.68 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144607697 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.17 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144607699 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.